Skip to main content
Fig. 3 | Inflammation and Regeneration

Fig. 3

From: Recent progress in pancreatic islet cell therapy

Fig. 3

Combining gene-editing and directed differentiation for the development of novel therapeutics. Patient-derived endocrine cells can be applied in disease modeling and drug testing, while corrected PSC-derived endocrine cells can be a promising source for autologous cell therapy

Back to article page

Inflammation and Regeneration

ISSN: 1880-8190

Contact us